SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-059363
Filing Date
2018-02-27
Accepted
2018-02-27 07:18:02
Documents
7
Period of Report
2018-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d511874d8k.htm 8-K 17727
2 EX-99.1 d511874dex991.htm EX-99.1 62665
3 EX-99.2 d511874dex992.htm EX-99.2 32244
4 EX-99.3 d511874dex993.htm EX-99.3 12862
5 GRAPHIC g511874g0223082954802.jpg GRAPHIC 3327
6 GRAPHIC g511874g21s79.jpg GRAPHIC 3222
7 GRAPHIC g511874g77d61.jpg GRAPHIC 6993
  Complete submission text file 0001193125-18-059363.txt   145847
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 18642917
SIC: 2834 Pharmaceutical Preparations